Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password
PMLiVE Top Pharma List

15

Revenue 2017

Novo Nordisk

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.

Novo Nordisk

Q&A: Niels Lund

Q&A: Niels Lund

PME interviews Novo Nordisk's Vice President, Health Advocacy. What gets you out of bed in the morning? ... Niels Lund is vice president of Health Advocacy at Novo Nordisk.

Gilead drives NASH development with insitro collaboration

Gilead drives NASH development with insitro collaboration Announcement comes days after Novo Nordisk deal. Gilead is further extending its work in non-alcoholic steatohepatitis (NASH), teaming up with San Francisco-based drug discovery group insitro for a ... For Gilead, the partnership marks the second deal in

Novo Nordisk and Gilead join forces in NASH

Novo Nordisk and Gilead join forces in NASH Will combine semaglutide with Gilead’s cilofexor and firsocostat. Novo Nordisk and Gilead are to collaborate on new combination treatments targeting non-alcoholic steatohepatitis (NASH) using Novo's diabetes drug semaglutide. ... The collaboration

Gottlieb signs off with flair – and pledge of further drug price commentary

Gottlieb signs off with flair – and pledge of further drug price commentary The high price of insulin is in the US headlines at the moment, with companies such as Novo Nordisk, Lilly and Sanofi under growing pressure to explain why their products have ... The US House Energy and Commerce oversight subcommittee is currently

Novo uses voucher for speedy answer on oral semaglutide

Novo uses voucher for speedy answer on oral semaglutide Oral version of Ozempic could be diabetes market leader. Novo Nordisk has filed its tablet form of diabetes injection Ozempic with the US FDA yesterday, and has used a priority review ... That's why oral semaglutide can't come soon enough to the market

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Global Data

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Quick links

Infographics

Multimedia